Pulmonary Disease, Chronic Obstructive: all 4,252 studies

Page 12 of 43. Open to participants first (707), then studies with results posted, then the rest; newest registration first within each.

• NVA237 BID Versus Placebo Twelve-week Efficacy StudyCompletedNCT01715298Phase 3Results posted
• Effects of Symbicort on the Ventilatory KinematicsTerminatedNCT01712854Phase 4Results posted
• A 12-week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow LimitationCompletedNCT01712516Phase 3Results posted
• A 26-week Treatment Randomized, Double-blind, Double Dummy Study to Assess the Efficacy and Safety of QVA149CompletedNCT01709903Phase 3Results posted
• NVA237 Versus Placebo 12-week Efficacy StudyCompletedNCT01709864Phase 3Results posted
• Beneficial Effects of Quercetin in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01708278Phase 1Results posted
• A Single-dose Study to Investigate the Effects of 4 Different Doses of Inhaled AZD8683 in Chronic Obstructive Pulmonary Disease (COPD) PatientsTerminatedNCT01708057Phase 2Results posted
• A Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary DiseaseCompletedNCT01706536Phase 2Results posted
• A Study to Assess the Efficacy of Fluticasone Furoate/Vilanterol (FF/VI) Inhalation Powder 100/25 mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50 mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01706328Phase 3Results posted
• 7 Days of TD-4208 in Subjects With Chronic Obstructive Pulmonary DiseaseCompletedNCT01704404Phase 2Results posted
• A Study to Characterize Pharmacokinetics of Tiotropium + Olodaterol Fixed-dose Combination in Japanese Patients With COPD.CompletedNCT01703845Phase 1Results posted
• Long-term Safety Study for GSK573719 in JapaneseCompletedNCT01702363Phase 3Results posted
• Swiss studY for the Treatment of COPD Patients With the Free combiNation of indacatERol and GlYcopyrroniumbromide.CompletedNCT01699685Phase 3Results posted
• Long Term Safety Study of NVA237 vs QAB149 in COPD PatientsCompletedNCT01697696Phase 3Results posted
• Functional Applications of Hyperpolarized 129Xe MRITerminatedNCT01697332Phase 1/2Results posted
• Co-administration of Olodaterol Respimat® and Tiotropium Handihaler®CompletedNCT01696058Phase 3Results posted
• Co-administration of Olodaterol Respimat® and Tiotropium Handihaler®CompletedNCT01694771Phase 3Results posted
• RELOVAIR® Lung Deflation StudyCompletedNCT01691885Phase 3Results posted
• A Study to Look at Day to Day Changes in Lung Function in COPD Subjects Taking Albuterol/Salbutamol and IpratropiumCompletedNCT01691482Phase 4Results posted
• A Multi-centre Randomized Double Blind 52-week Study to Assess the Safety of QVA149 Compared to QAB149 in Patients With COPD Who Have Moderate to Severe Airflow LimitationCompletedNCT01682863Phase 3Results posted
• Study to Compare (COPD) Assessment Test in COPD Stage III and IV in a Prophylactic TreatmentCompletedNCT01679314Not applicableResults posted
• BYM338 in Chronic Obstructive Pulmonary Disease (COPD) Patients With CachexiaCompletedNCT01669174Phase 2Results posted
• Investigate the Impact of Early Treatment Initiation With Tiotropium in Patients Recovering From Hospitalization for an Acute COPD Exacerbation 1CompletedNCT01663987Phase 4Results posted
• Investigate the Impact of Early Treatment Initiation With Tiotropium in Patients Recovering From Hospitalization for an Acute COPD Exacerbation 2CompletedNCT01662986Phase 4Results posted
• A Study to Evaluate Efficacy and Safety Profile of Zabofloxacin Tablet 400mg and Moxifloxacin Tablet 400mgCompletedNCT01658020Phase 3Results posted
• Assessment of Health-status of Patients With Chronic Obstructive Pulmonary Disease (COPD) on Maintenance Therapy With Spiriva HH Measured by COPD Assessment Test (CAT) TestCompletedNCT01644734Phase 4Results posted
• A 24-week Study to Evaluate the Efficacy and Safety of GSK573719/GW642444 125/25 mcg and 62.5/25mcg Inhalation Powder Compared With Placebo in Subjects With COPDCompletedNCT01636713Phase 3Results posted
• Efficacy and Safety of QMF149 vs. Salmeterol Xinafoate/Fluticasone Propionate in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01636076Phase 2Results posted
• Use of FeNO to Identify Eosinophilic Inflammation in Patients Age 40 Years and Above With Chronic Obstructive Airways DiseaseCompletedNCT01634620Results posted
• Effects of ROFLUMILAST on Subclinical Atherosclerosis in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01630200Phase 4Results posted
• Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate/Vilanterol (FF/VI) Inhalation Powder 100/25mcg Once Daily Compared With Tiotropium Bromide Inhalation Powder 18mcg Once Daily in Subjects With COPD Who Have or Are At Risk for Co-morbid Cardiovascular DiseaseCompletedNCT01627327Phase 3Results posted
• Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant SuitabilityCompletedNCT01615484Not applicableResults posted
• Efficacy, Safety, and Tolerability of NVA237 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01613326Phase 3Results posted
• Vagus Nerve Stimulation for Management of Bronchoconstriction in Patients Hospitalized With COPD ExacerbationsTerminatedNCT01612793Results posted
• Comparison of Long-term Safety of the Combination Product QVA149A Against Placebo and Standard of Care Treatment in Chronic Obstructive Pulmonary Disease Patients With Moderate to Severe Airflow LimitationCompletedNCT01610037Phase 3Results posted
• ADOAIR250 Anti-inflammatory Effects in Japanese Subjects With Chronic Obstructive Pulmonary DiseaseCompletedNCT01607398Phase 4Results posted
• Efficacy, Safety and Tolerability of the Co-administration of NVA237 Plus Indacaterol Once Daily Versus Indacaterol Once Daily in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01604278Phase 3Results posted
• Validation of the AVAPS AE Algorithm in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT01601977Phase 2/3Results posted
• Glycopyrrolate/Formoterol Fumarate MDI Compared With Spiriva® as An Active Control in Patients With Moderate to Severe Chronic Obstructive Pulmonary DiseaseCompletedNCT01587079Phase 2Results posted
• The Role of Substance P on Perception of Breathlessness During Resistive Load BreathingCompletedNCT01580423Not applicableResults posted
• Telemonitoring of Patients With COPD in CarinthiaCompletedNCT01580072Not applicableResults posted
• Mindfulness Mediation Intervention in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01577329Not applicableResults posted
• The Effect of QVA149 on Health Related Quality of Life in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01574651Phase 3Results posted
• A Placebo-controlled Trial of Daliresp on Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01572948Not applicableResults posted
• Efficacy, Safety and Tolerability of Two Fixed Dose Combinations of Aclidinium Bromide/Formoterol Fumarate, Aclidinium Bromide, Formoterol Fumarate and Placebo for 28-Weeks Treatment in Patients With Moderate to Severe, Stable Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01572792Phase 3Results posted
• PT001 MDI Versus Spiriva® in Patients With Moderate to Severe COPDCompletedNCT01566773Phase 2Results posted
• Efficacy, Safety and Tolerability of NVA237 in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT01566604Phase 3Results posted
• Magnesium is Associated With QoL in COPD: A Cross-sectional StudyCompletedNCT01564953Results posted
• Characterization of 24-hour Lung Function Profiles of Inhaled Tiotropium + Olodaterol Fixed Dose Combination in Patients Suffering From Chronic Obstructive Pulmonary DiseaseCompletedNCT01559116Phase 3Results posted
• Comparison of Indacaterol 150 mcg Once Daily (o.d.) With Salmeterol/Fluticasone Propionate 50 mcg/500 mcg Twice Daily (b.i.d.)CompletedNCT01555138Phase 4Results posted
• Inhaled Fluticasone Effects on Upper Airway Patency in Obstructive Lung DiseaseTerminatedNCT01554488Phase 4Results posted
• Pharmacokinetic, Safety and Tolerability Study of Aclidinium/Formoterol Fixed Dose Combination and Formoterol in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01551888Phase 2Results posted
• A Randomised Effectiveness Study Comparing Fluticasone Furoate (FF, GW685698)/Vilanterol (VI, GW642444) With Standard Treatment in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01551758Phase 3Results posted
• Indacaterol 75 μg Compared to Placebo, Assessing Time to Patient's Perception of Onset of Effect in Patients With Moderate to Severe Chronic Obstructive Pulmonary DiseaseCompletedNCT01543828Phase 4Results posted
• Effects of Salmeterol on Autonomic Nervous SystemCompletedNCT01536587Phase 4Results posted
• Japan Long-term Safety for Tiotropium Plus OlodaterolCompletedNCT01536262Phase 3Results posted
• Effect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD Patients.CompletedNCT01533935Phase 3Results posted
• Effect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD PatientsCompletedNCT01533922Phase 3Results posted
• Comparison of Safety and Efficacy of the Combination Product QVA149A Against the Concurrent Administration of the Individual Components, QAB149 and NVA237, in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01529632Phase 3Results posted
• A Study to Determine the Effect of Tiotropium + Olodaterol Fixed Dose Combination on Exercise Endurance Time During Constant Work Rate Cycle Ergometry Test in COPDCompletedNCT01525615Phase 3Results posted
• Efficacy, Tolerability and Safety of NVA237 in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT01513460Phase 3Results posted
• Trial to Assess the Anti-inflammatory Effects of Roflumilast in Chronic Obstructive Pulmonary DiseaseCompletedNCT01509677Phase 3Results posted
• Pharmacokinetic and Pharmacodynamic (PK and PD) Study of Fluticasone Propionate and Salmeterol Combination Product Delivered in a Capsule-based Inhaler and in a Multi-dose Dry Powder Inhaler in Moderate Asthma Patients and Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Patients.CompletedNCT01494610Phase 1/2Results posted
• The Effect of QVA149 on Patient Reported Dyspnea in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01490125Phase 3Results posted
• Tiotropium (18mcg) in Chronic Obstructive Pulmonary Disease (COPD) Patients With a Respiratory InfectionCompletedNCT01483625Phase 4Results posted
• Effect of Roflumilast at Acute Exacerbations of Chronic Obstructive Pulmonary DiseaseTerminatedNCT01473758Phase 2Results posted
• Efficacy and Safety of Aclidinium Bromide 400 µg BID (Twice a Day)Compared to Placebo in Patients With Stable Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01471171Phase 3Results posted
• Mepolizumab in Chronic Obstructive Pulmonary Diseases (COPD) With Eosinophilic BronchitisCompletedNCT01463644Phase 3Results posted
• Long-term Efficacy and Safety of Aclidinium Bromide/Formoterol Fumarate Fixed-Dose CombinationCompletedNCT01462942Phase 3Results posted
• Efficacy and Safety of Aclidinium Bromide 400 µg Compared to Placebo and to Tiotropium Bromide in Patients With Stable Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01462929Phase 3Results posted
• A Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary DiseaseCompletedNCT01448850Phase 2Results posted
• Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS)CompletedNCT01443845Phase 4Results posted
• Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)TerminatedNCT01437878Phase 2Results posted
• Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary DiseaseCompletedNCT01437540Phase 3Results posted
• Efficacy, Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Aclidinium Bromide and Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01437397Phase 3Results posted
• Tiotropium +Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01431287Phase 3Results posted
• Tiotropium+Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01431274Phase 3Results posted
• Effectiveness of Interventions to Teach Respiratory Inhaler Technique (E-TRaIN)CompletedNCT01426581Not applicableResults posted
• Study to Investigate the Dose Response, Safety and Efficacy of Nebulized EP-101(SUN101) in Patients With Chronic Obstructive Pulmonary Disease (COPD): GOLDEN-1 StudyCompletedNCT01426009Phase 2Results posted
• Single Dose Study to Assess Efficacy and Safety of 4 Doses of LAS100977 in Chronic Obstructive Pulmonary Disease (COPD) PopulationCompletedNCT01425814Phase 2Results posted
• Efficacy and Tolerability Study in Severe Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT01415518Phase 4Results posted
• Nitric Oxide Bioavailability in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01398943Not applicableResults posted
• Efficacy and Tolerability of Symbicort as an add-on Treatment to Spiriva Compare With Spiriva Alone in Patients With Severe Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01397890Phase 4Results posted
• A Study to Compare the Impact of Fulticasone Furoate/Vilanterol vs. Tiotropium on Arterial Stiffness in COPDCompletedNCT01395888Phase 3Results posted
• Efficacy of Inhaling Bronchodilator Medications in Chronic Obstructive Pulmonary DiseaseCompletedNCT01391559Not applicableResults posted
• Efficacy and Safety Study of Tesamorelin in Chronic Obstructive Pulmonary Disease (COPD) Subjects With Muscle WastingTerminatedNCT01388920Phase 2Results posted
• ADESPI: Adherence to Spiriva® in Patients With COPD (Chronic Obstructive Pulmonary Disease), Measured by Morisky-8 (MMAS-8) Scale, in Routine Medical PracticeCompletedNCT01388166Results posted
• Evaluate the Efficacy and Safety of GSK573719 Delivered Via a Novel Dry Powder Inhaler in Subjects With COPDCompletedNCT01387230Phase 3Results posted
• Outcomes From Initial Maintenance Therapy With Fluticasone Propionate 250/Salmeterol 50 (FSC) or Tiotropium in Chronic Obstructive Pulmonary DiseaseCompletedNCT01387178Results posted
• Study Evaluating Preference, Satisfaction and Ease of Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD) Diagnosed PatientsCompletedNCT01385696Phase 3Results posted
• Fluticasone Propionate-salmeterol Combination Adherence in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01381471Results posted
• Impact of Initiating Tiotropium Alone Versus Initiating Tiotropium in Combination With Fluticasone Propionate/Salmeterol Xinafoate Combination (FSC) on Chronic Obstructive Pulmonary Disease-related Outcomes in Patients With Pre-existing ExacerbationsCompletedNCT01381406Results posted
• Effects of Vibration Training on Exercise Capacity in COPD-patientsCompletedNCT01380639Not applicableResults posted
• Effect of Ketoconazole on BreathlessnessCompletedNCT01378520Phase 4Results posted
• Long-term Safety Study for GSK573719/GW642444 in JapaneseCompletedNCT01376388Phase 3Results posted
• A 24-week Study of Fluticasone Furoate/Vilanterol Inhalation Powder in Subjects of Asian Ancestry With COPDCompletedNCT01376245Phase 3Results posted
• Effects of the Breathe Technologies Ventilation System in Subjects With Chronic Obstructive Pulmonary DiseaseCompletedNCT01372462Not applicableResults posted
• A Randomized, Double Blind, Placebo Controlled, Incomplete Block, Crossover, Dose Ranging Study to Evaluate the Dose Response of GSK573719 Administered Once or Twice Daily Over 7 Days in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01372410Phase 2Results posted
• Non-invasive Ventilation System in Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01355978Not applicableResults posted
• PT001 MDI Versus Atrovent Study in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01350128Phase 2Results posted

← Pulmonary Disease, Chronic Obstructive overview